Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study

By Angioli Roberto   Plotti Francesco   Luvero Daniela   Aloisi Alessia   Guzzo Federica   Capriglione Stella   Terranova Corrado   Cicco Nardone Carlo   Benedetti-Panici Pierluigi  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2741-2746

Springer Publishing Company

Access to resources Recommend Favorite

Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration

By Polistina Francesco  

Annals of Surgical Oncology, Vol. 17, Iss. 8, 2010-08 ,pp. : 2092-2101

Springer Publishing Company

Access to resources Recommend Favorite

Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study

By Koie Takuya   Ohyama Chikara   Hashimoto Yasuhiro   Hatakeyama Shingo   Yamamoto Hayato   Yoneyama Takahiro   Kamimura Noritaka  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 724-730

Springer Publishing Company

Access to resources Recommend Favorite

A feasibility study of carboplatin with fixed dose of gemcitabine in 'unfit' patients with advanced bladder cancer

By Bellmunt J.   de Wit R.   Albanell J.   Baselga J.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2212-2215

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer

By Soetekouw Patricia   Timmer-Bonte Johanna   Drift Miep   Leeuwen Frank   Wagenaar Michiel   Die Lya   Bussink Jan   Tjan-Heijnen Vivianne  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 988-996

Springer Publishing Company

Access to resources Recommend Favorite